Percutaneous treatment of peripheral artery disease: Novel techniques

Circulation

Volumn 126, Issue 20, 2012, Pages 2433-2440

  Schillinger, Martin ^a   Minar, Erich ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

coronary restenosis; endovascular procedures; percutaneous treatment; peripheral arterial disease

Indexed keywords

CHROMIUM; COBALT; EVEROLIMUS; HEPARIN; PACLITAXEL; RAPAMYCIN;

ARTICLE; ATHERECTOMY; BALLOON; BALLOON EXPANDING STENT; BARE METAL STENT; BYPASS SURGERY; CARDIOVASCULAR EQUIPMENT; CATHETER; CRITICAL LIMB ISCHEMIA; DRUG ELUTING BALLOON; DRUG ELUTING STENT; EXCIMER LASER; EXCIMER LASER ATHERECTOMY; FEMOROPOPLITEAL BYPASS; HUMAN; ILIAC ARTERY; IN-STENT RESTENOSIS; INTERMETHOD COMPARISON; INTERMITTENT CLAUDICATION; MATERIAL COATING; MULTICENTER STUDY (TOPIC); NITINOL STENT; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POPLITEAL ARTERY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESTENOSIS; ROTATIONAL ATHERECTOMY; SELF EXPANDING STENT; STENT; SUPERFICIAL FEMORAL ARTERY; TREATMENT INDICATION;

ANGIOPLASTY; ANGIOPLASTY, BALLOON; ATHERECTOMY; DRUG-ELUTING STENTS; HUMANS; PERIPHERAL ARTERIAL DISEASE; TREATMENT OUTCOME;

EID: 84869199164     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.111.036574     Document Type: Article

References (44)

1. Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD): TASC Working Group: TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg. 2000;31:S1-S296.
2. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg. 2007;45:S5-S67. (Pubitemid 46151680)
3. Johnston KW. Femoral and popliteal arteries: reanalysis of results of balloon angioplasty. Radiology. 1992;183:767-771.
4. Schillinger M, Sabeti S, Loewe C, Dick P, Amighi J, Schlager O, Mlekusch W, Cejna M, Lammer J, Minar E. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med. 2006;354:1879-1888. (Pubitemid 43872689)
5. Ponec D, Jaff MR, Swischuk J, Feiring A, Laird J, Mehra M, Popma JJ, Donohoe D, Firth B, Keim E, Snead D; CRISP Study Investigators. The nitinol SMART stent vs. Wallstent for suboptimal iliac artery angioplasty: CRISP-US trial results. J Vasc Interv Radiol. 2004;15:911-918. (Pubitemid 39249845)
6. Biondi-Zoccai GG, Sangiorgi G, Lotrionte M, Feiring A, Commeau P, Fusaro M, Agostoni P, Bosiers M, Peregrin J, Rosales O, Cotroneo AR, Rand T, Sheiban I. Infragenicular stent implantation for below-the-knee atherosclerotic disease: clinical evidence from an international collaborative meta-analysis on 640 patients. J Endovasc Ther. 2009;16:251-260.
7. Schillinger M, Sabeti S, Dick P, Amighi J, Mlekusch W, Schlager O, Loewe C, Cejna M, Lammer J, Minar E. Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Circulation. 2007;115:2745-2749. (Pubitemid 46842791)
8. Bausback Y, Botsios S, Flux J, Werner M, Schuster J, Aithal J, Varcoe R, Bräunlich S, Ulrich M, Scheinert D, Schmidt A. Outback catheter for femoropopliteal occlusions: immediate and long-term results. J Endovasc Ther. 2011;18:13-21.
9. Tetteroo E, van der Graaf Y, Bosch JL, van Engelen AD, Hunink MG, Eikelboom BC, Mali WP. Randomised comparison of primary stent placement versus primary angioplasty followed by selective stent placement in patients with iliac-artery occlusive disease: Dutch Iliac Stent Trial Study Group. Lancet. 1998; 351:1153-1159. (Pubitemid 28171817)
10. Treiman GS, Schneider PA, Lawrence PF, Pevec WC, Bush RL, Ichikawa L. Does stent placement improve the results of ineffective or complicated iliac artery angioplasty? J Vasc Surg. 1998;28:104-112.
11. Klein WM, van der Graaf Y, Seegers J, Spithoven JH, Buskens E, van Baal JG, Buth J, Moll FL, Overtoom TT, van Sambeek MR, Mali WP. Dutch Iliac Stent Trial: long-term results in patients randomized for primary or selective stent placement. Radiology. 2006;238:734-744. (Pubitemid 43134389)
12. Beattie GC, Brittenden J, Gillespie I, McBride K, McInnes G, Bradbury AW. Vascular surgical society of Great Britain and Ireland: outcome of iliac percutaneous transluminal angioplasty with and without the use of stents in patients with intermittent claudication. Br J Surg. 1999;86:704-705.
13. Bosch JL, Tetteroo E, Mali WP, Hunink MG. Iliac arterial occlusive disease: cost-effectiveness analysis of stent placement versus percutaneous transluminal angioplasty: Dutch Iliac Stent Trial Study Group. Radiology. 1998;208:641-648. (Pubitemid 28405097)
14. Minar E, Pokrajac B, Maca T, Ahmadi R, Fellner C, Mittlböck M, Seitz W, Wolfram R, Pötter R. Endovascular brachytherapy for prophylaxis of restenosis after femoropopliteal angioplasty: results of a prospective randomized study. Circulation. 2000;102:2694-2699.
15. Capek P, McLean GK, Berkowitz HD. Femoropopliteal angioplasty: factors influencing long-term success. Circulation. 1991;83(suppl):I-70-I-80.
16. Vroegineweij D, Vos LD, Tielbeek AV, Buth J, vd Bosch HC. Balloon angioplasty combined with primary stenting versus balloon angioplasty alone in femoropopliteal obstructions: a comparative randomized study. Cardiovasc Intervent Radiol. 1997;20:420-425. (Pubitemid 27512031)
17. Grimm J, Muller-Hulsbeck S, Jahnke T, Hilbert C, Brossmann J, Heller M. Randomized study to compare PTA with Palmaz stent placement for femoropopliteal lesions. J Vasc Intervent Radiol. 2001;12:935-942.
18. Zdanowski Z, Albrechtsson U, Lundin A, Jonung T, Ribbe E, Thörne J, Norgren L. Percutaneous transluminal angioplasty with or without stenting for femoropopliteal occlusions? A randomized controlled study. Int Angiol. 1999;18:251-255. (Pubitemid 30153799)
19. Becquemin JP, Favre JP, Marzelle J, Nemoz C, Corsin C, Leizorovicz A. Systematic vs. selective stent placement after superficial femoral artery balloon angioplasty: a multicenter prospective randomised study. J Vasc Surg. 2003;37:487-494. (Pubitemid 36350887)
20. Dick P, Wallner H, Sabeti S, Loewe C, Mlekusch W, Lammer J, Kop-pensteiner R, Minar E, Schillinger M. Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions. Catheter Cardiovasc Interv. 2009;74:1090-1095.
21. Krankenberg H, Schlüter M, Steinkamp HJ, Bürgelin K, Scheinert D, Schulte KL, Minar E, Peeters P, Bosiers M, Tepe G, Reimers B, Mahler F, Tübler T, Zeller T. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the Femoral Artery Stenting Trial (FAST). Circulation. 2007; 116:285-292. (Pubitemid 47196564)
22. Laird JR, Katzen BT, Scheinert D, Lammer J, Carpenter J, Buchbinder M, Dave R, Ansel G, Lansky A, Cristea E, Collins TJ, Goldstein J, Jaff MR; RESILIENT Investigators. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial. Circ Cardiovasc Interv. 2010;3:267-276.
23. Scheinert D, Grummt L, Piorkowski M, Sax J, Scheinert S, Ulrich M, Werner M, Bausback Y, Braunlich S, Schmidt A. A novel self-expanding interwoven nitinol stent for complex femoropopliteal lesions:24-month results of the SUPERA SFA Registry. J Endovasc Ther. 2011;18:745-752.
24. Bosiers M, Deloose K, Callaert J, Moreels N, Keirse K, Verbist J, Peeters P. One-year results with the Protégé EverFlex 200-mm-long nitinol stent (ev3) in TransAtlantic Inter-Society Consensus C and D femoropopliteal lesions: Durability-200 Study. J Vasc Surg. 2011;54:1042-1050.
25. Duda SH, Bosiers M, Lammer J, Scheinert D, Zeller T, Oliva V, Tielbeek A, Anderson J, Wiesinger B, Tepe G, Lansky A, Jaff MR, Mudde C, Tielemans H, Beregi JP. Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial. J Endovasc Ther. 2006;13:701-710. (Pubitemid 44907633)
26. Lammer J, Bosiers M, Zeller T, Schillinger M, Boone E, Zaugg MJ, Verta P, Peng L, Gao X, Schwartz LB. First clinical trial of nitinol self-expanding everolimus-eluting stent implantation for peripheral arterial occlusive disease. J Vasc Surg. 2011;54:394-401.
27. Dake MD, Scheinert D, Tepe G, Tessarek J, Fanelli F, Bosiers M, Ruhlmann C, Kavteladze Z, Lottes AE, Ragheb AO, Zeller T; Zilver PTX Single-Arm Study Investigators. Nitinol stents with polymer-free pac-litaxel coating for lesions in the superficial femoral and popliteal arteries above the knee: twelve-month safety and effectiveness results from the Zilver PTX single-arm clinical study. J Endovasc Ther. 2011;18:613-623.
28. Dake MD, Ansel GM, Jaff MR, Ohki T, Saxon RR, Smouse HB, Zeller T, Roubin GS, Burket MW, Khatib Y, Snyder SA, Ragheb AO, White JK, Machan LS; Zilver PTX Investigators. Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropop-liteal disease: twelve-month Zilver PTX randomized study results. Circ Cardiovasc Interv. 2011;4:495-504.
29. Dake M. Abstract and Lecture presented at: International Symposium on Endovascular Therapy; January 16-20, 2011; Miami Beach, FL.
30. Rastan A, Tepe G, Krankenberg H, Zahorsky R, Beschorner U, Noory E, Sixt S, Schwarz T, Brechtel K, Böhme C, Neumann FJ, Zeller T. Sirolimus-eluting stents vs. bare-metal stents for treatment of focal lesions in infrapopliteal arteries: a double-blind, multi-centre, randomized clinical trial. Eur Heart J. 2011;32:2274-2281.
31. Scheinert D. Abstract and Lecture presented at: Leipzig Interventional Course; January 19-22, 2011; Leipzig, Germany.
32. Bosiers M, Scheinert D, Peeters P, Torsello G, Zeller T, Deloose K, Schmidt A, Tessarek J, Vinck E, Schwartz LB. Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease. J Vasc Surg. 2012;55:390-398.
33. Peeters P, Keirse K, Verbist J, Deloose K, Bosiers M. Are bio-absorbable stents the future of SFA treatment? J Cardiovasc Surg (Torino). 2010; 51:121-124.
34. Sharma S, Kukreja N, Christopoulos C, Gorog DA. Drug-eluting balloon: new tool in the box. Expert Rev Med Devices. 2010;7:381-388.
35. Zeller T, Schmitmeier S, Tepe G, Rastan A. Drug-coated balloons in the lower limb. J Cardiovasc Surg (Torino). 2011;52:235-243.
36. Tepe G, Zeller T, Albrecht T, Heller S, Schwarzwälder U, Beregi JP, Claussen CD, Oldenburg A, Scheller B, Speck U. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med. 2008;358:689-699. (Pubitemid 351240748)
37. Werk M, Langner S, Reinkensmeier B, Boettcher HF, Tepe G, Dietz U, Hosten N, Hamm B, Speck U, Ricke J. Inhibition of restenosis in fem-oropopliteal arteries: paclitaxel-coated versus uncoated balloon: Femoral Paclitaxel randomized pilot trial. Circulation. 2008;118:1358-1365.
38. Scheinert D. Abstract and Lecture presented at: Transcatheter Cardiovascular Therapeutics; September 21-25, 2010; Washington, DC.
39. Schmidt A. Abstract and Lecture presented at: Leipzig Interventional Course; January 19-22, 2011; Leipzig, Germany.
40. Shammas NW, Coiner D, Shammas GA, Dippel EJ, Christensen L, Jerin M. Percutaneous lower extremity arterial interventions with primary balloon angioplasty versus SilverHawk Atherectomy and adjunctive balloon angioplasty: randomized trial. J Vasc Interv Radiol. 2011;22:1223-1228.
41. Korabathina R, Mody KP, Yu J, Han SY, Patel R, Staniloae CS. Orbital atherectomy for symptomatic lower extremity disease. Catheter Car-diovasc Interv. 2010;76:326-332.
42. Micari A, Vadala G, Biamino G. Update on the Turbo Booster spectra-netics laser for lower extremity occlusive disease. J Cardiovasc Surg (Torino). 2010;51:233-243.
43. Kedora J, Hohmann S, Garrett W, Munschaur C, Theune B, Gable D. Randomized comparison of percutaneous Viabahn stent grafts vs. prosthetic femoropopliteal bypass in the treatment of superficial femoral occlusive disease. J Vasc Surg. 2007;45:10-16. (Pubitemid 46038657)
44. Saxon RR, Dake MD, Volgelzang RL, Katzen BT, Becker GJ. Randomized, multicenter study comparing expanded polytetrafluorethylene-covered endoprosthesis placement with percutaneous transluminal angio-plasty in the treatment of superficial femoral artery occlusive disease. J Vasc Interv Radiol. 2008;19:823-832. (Pubitemid 351713526)